Aqueous extract of Monascus purpureus M9011 prevents and reverses fructose-induced hypertension in rats

Journal of Agricultural and Food Chemistry

Volumn 51, Issue 14, 2003, Pages 3945-3950

  Hsieh, Po Shiuan ^a,b   Tai, Yueh Hua ^a  

^a NATIONAL DEFENSE UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Dyslipidemia; Fructose; GABA; Hyperinsulinemia; Hypertension; Hypertriglyceridemia; Insulin resistance; Monascus purpureus M9011; Rats

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; FRUCTOSE; GLUCOSE; INSULIN; MONASCUS PURPUREUS EXTRACT; NATURAL PRODUCT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ISOLATION; DYSLIPIDEMIA; FUNGUS; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MEAN ARTERIAL PRESSURE; METABOLISM; MONASCUS PURPUREUS; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, HDL; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HEART RATE; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MONASCUS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

ANIMALIA; FUNGI; MONASCUS; MONASCUS PURPUREUS;

EID: 0037677440     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf026157n     Document Type: Article

References (32)

1. DeFronzo, R. A.; Ferrannini, E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14, 173-194.
2. U.K. Prospective Diabetes Study. III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. A multicenter study. Hypertension 1985, 7 (6 pt 2), 118-13.
3. Drury, P. L. Diabetes and arterial hypertension. Diabetologia 1983, 23, 1-9.
4. Fuller, J. H. Epidemiology of hypertension associated with diabetes mellitus. Hypertension 1985, 7 (6 Pt 2), 113-7.
5. Parving, H. H.; Andersen, A. R.; Smidt, U. M.; Hommel E.; Mathiesen, E. R.; Svendsen, P. A. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br. Med. J. Clin. Res. Ed. 1987, 294 (6585), 1443-1447.
6. Hasslacher, C.; Stech, W.; Wahl, P.; Ritz, E. Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1985, 28 (1), 6-11.
7. Hypertension in Diabetes Study (HDS) II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J. Hypertens. 1993, 11 (3), 319-325.
8. Janka, H. U.; Warram, J. H.; Rand, L. I.; Krolewski, A. S. Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes 1989, 38 (4), 460-464.
9. Hwang, I. S.; Ho, H.; Hoffman, B. B.; Reaven, G. M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987, 10, 512-516.
10. Hwang, I. S.; Huang, W. C.; Wu, J. N.; Shieh, L. R.; Reaven, G. M. Effect of fructose-induced hypertension on the renin-angiotensin-aldosterone system and atrial natriuretic factor. Am. J. Hypertens. 1989, 2, 424-427.
11. Ying, S. S.; T'ien Jung K'ai, Wu. Chinese Technology in the Seventeenth Century; Sun, E.-T., Sun, S.-C., transl.; Pennsylvania State University Press: State College, PA, 1966; pp 291-294.
12. Kohama, Y.; Matsumoto, S.; Mimura, T.; Tanabe, N.; Inada, A.; Nakanishi, T. Isolation and identification of hypotensive principles in red-mold rice. Chem. Pharm. Bull. 1987, 35 (6), 2484-2489.
13. Tsuji, K.; Ichikawa, T.; Tanabe, N.; Abe, S.; Tarui, S.; Nakagawa, Y. Antihypertensive activity of beni-koji extracts and γ-aminobutyric acid in spontaneously hypertensive rats. Jpn. J. Nutr. 1992, 50 (5), 285-291.
14. Kushiro, T.; Hashida, J.; Kawamura, H.; Mitsubayashi, H.; Saito, T.; Suzuki, Y.; Takahashi, N.; Ishii, T.; Kimura, T.; Tsuji, K.; Tanabe, N.; Asano, K.; Abe, S.; Tarui, S. Clinical effects of benikoji in mild essential hypertension - a multicenter double-blind comparison with placebo. Jpn. J. Nephrol. 1996, 38, 625-633.
15. Zhang, G.; Bown, A. W. The rapid determination of γ-aminobutyric acid. Phytochemistry 1997, 44, 1007-1009.
16. Endo, A.; Monacolin, K. A new hypocholesterolemic agent produced by a Monascus species. J. Antibiot. 1979, 32, 852-854.
17. Endo, A.; Monacolin, K. A new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Antibiot. 1980, 33, 334-336.
18. Endo, A.; Hasumi, K.; Nakamura, T.; Kunishima, M.; Masuda, M. Dihydromonacolin L and monacolin Y new metabolites those inhibit cholesterol biosynthesis. J. Antibiot. 1985, 38, 321-327.
19. Blanc, P. J.; Laussac, J. P.; Bars, J.; LeBars, P.; LeLoret, M. D.; Pareilleux, A.; Prome, D.; Prome, J. C.; Santerre, A. L.; Goma, G. Characterization of monascidin A from Monascus as citrinin. Int. J. Food Microbiol. 1995, 27, 201-213.
20. Hsieh, P. S.; Huang, W. C. Chemical sympathectomy attenuates hyperinsulinemia-induced hypertension in conscious rats. Nutr. Metab. Cardiovasc. Dis. 1993, 3, 173-178.
21. Hsieh, P. S.; Huang, W. C. Neonatal chemical sympathectomy attenuates fructose-induced hypertriglyceridemia and hypertension in rats. Chin. J. Physiol. 2001, 44 (1), 25-31.
22. Furchgott, R. F.; Zawadzki, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288 (5789), 373-376.
23. Giuliani, S.; Maggi, C. A.; Meli, A. Differences in cardiovascular responses to peripherally administered GABA as influenced by basal conditions and type of anaesthesia. Br. J. Pharmacol. 1986, 88 (3), 659-670.
24. Wang, I. K.; Lin-Shiau, S.-Y.; Chen, P.-C.; Lin, J.-K. Hypotriglyceridemic effect of Anka (a fermented rice product of Monascus sp.) in rats. J. Agric. Food Chem. 2000, 48, 3183-3189.
25. Smith, W. M. Treatment of mild hypertension: results of a tenyear intervention trial. Circ. Res. 1977, 40 (5 Suppl. 1), 198-105.
26. Veterans administration cooperative study group or antihypertensive agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mmHg. JAMA - J. Am. Med. Assoc. 1967, 202, 1028.
27. Veterans administration cooperative study group or antihypertensive agents: effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA - J. Am. Med. Assoc. 1970, 213, 143.
28. Hebert, P. R.; Marson, J.; Henrekers, C. H. Pharmacologic therapy of mild to moderate hypertension: possible generalizability to diabetes. J. Am. Soc. Nephrol. 1992, 3, S135.
29. Weidmann, P.; Uehlinger, D. E.; Gerber, A. Antihypertensive treatment and serum lipoproteins. J. Hypertens. 1985, 3, 297.
30. Weinberger, M. H. Antihypertensive therapy and lipids: evidence, mechanisms and implications. Arch. Intern. Med. 1985, 145, 1102.
31. Warram, J. H.; Laffel, L. M.; Valsania, P.; Christlieb, A. R.; Krolewski, A. S. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch. Intern. Med. 1991, 151, 1350.
32. Bilgrami, K. S.; Sinha, S. P.; Jeswal, P. Nephrotoxic and hepatotoxic effects of citrinin in mice. Proc. Indian Natl. Sci. Acad. 1988, 54, 35-37.